Cullen/Frost Bankers’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200
Closed -$10K 1021
2023
Q3
$10K Hold
200
﹤0.01% 924
2023
Q2
$10.7K Hold
200
﹤0.01% 915
2023
Q1
$9.79K Hold
200
﹤0.01% 952
2022
Q4
$10.4K Hold
200
﹤0.01% 918
2022
Q3
$9K Hold
200
﹤0.01% 944
2022
Q2
$10K Hold
200
﹤0.01% 909
2022
Q1
$10K Hold
200
﹤0.01% 940
2021
Q4
$11K Hold
200
﹤0.01% 952
2021
Q3
$11K Hold
200
﹤0.01% 1047
2021
Q2
$12K Hold
200
﹤0.01% 1042
2021
Q1
$13K Hold
200
﹤0.01% 894
2020
Q4
$11K Hold
200
﹤0.01% 899
2020
Q3
$11K Hold
200
﹤0.01% 887
2020
Q2
$12K Hold
200
﹤0.01% 879
2020
Q1
$13K Hold
200
﹤0.01% 689
2019
Q4
$13K Hold
200
﹤0.01% 863
2019
Q3
$13K Hold
200
﹤0.01% 792
2019
Q2
$13K Hold
200
﹤0.01% 779
2019
Q1
$12K Buy
+200
New +$11.9K ﹤0.01% 730

Other funds holding AMSF

Cullen/Frost Bankers's AMSF Position: Q4 2023 in Review

Cullen/Frost Bankers sold out of AMERISAFE (AMSF) in Q4 2023, closing a stake of 200 shares — an estimated $10K sold.

Cullen/Frost Bankers first reported a position in AMSF in Q1 2019 and held it in 19 quarters. The position peaked at $13K in Q1 2021. 162 funds tracked by Wall St. Rank hold AMSF as of Q4 2023.

  • Cullen/Frost Bankers reported no remaining AMERISAFE position as of Q4 2023 after selling out during the quarter.
  • Cullen/Frost Bankers sold 200 AMERISAFE shares in Q4 2023, an estimated $10K.
  • Cullen/Frost Bankers first reported a position in AMERISAFE in Q1 2019 and held it in 19 quarters.
  • Cullen/Frost Bankers's AMERISAFE position peaked at $13K in Q1 2021.
  • 162 funds tracked by Wall St. Rank held AMERISAFE as of Q4 2023.

Based on Cullen/Frost Bankers's 13F filing for Q4 2023, filed 6 Feb 2024.